Australia Seeks Views On Revised National Medicines Policy
Executive Summary
As part of its ongoing review of the National Medicines Policy, Australia’s Department of Health calls for “robust and transparent prioritization of spending on medicines” as well as a collective approach to ensuring speedy and equitable access to affordable medicines for all communities.
You may also be interested in...
Australia To Address Supply Chain Issues In Medicines Access Review
Stakeholders are being asked to say what they think of plans to future-proof the framework that governs access to medicines and is intended to help bolster the pharmaceutical sector.
Stakeholders Gather To Discuss Pandemic Response And Next Steps
As Europe’s health emergency body HERA approaches its first anniversary, an unprecedented range of stakeholders including industry bodies will be meeting in December to discuss HERA’s achievements, while a separate event will showcase the next generation of vaccines for COVID-19 and other infections.
EU Wants Legislative Review To Support ‘World Class’ Pharmaceutical Industry
The European health commissioner has told members of parliament that a balance needs to be struck between promoting innovation and maximizing access to medicines across the EU member states.